Saturday, July 12, 2025
HomeIndustriesHealthcare

Healthcare

Brexogen’s Exosome Therapy for Atopic Dermatitis, ‘BRE-AD01’ Accepted for Phase 1 Clinical Trials

The US FDA granted the initiation of the phase 1 clinical trial of 'BRE-AD01', an exosome- based therapy for atopic dermatitis. 'BRE-AD01' is being...

MicroPort Orthopedics Releases the HIPTURN Tensioning Instrument: An Exclusive in-situ Trialing Device

MicroPort Orthopedics is a medical device company specializing in large joint replacements with clinical data/history dating back over 20 years. Building upon that legacy,...

CathVision Announces Initiation of Clinical Study Evaluating Signal Complexity Algorithm

CathVision, a medical technology company developing innovative electrophysiology solutions to enhance clinical decision-making in the EP lab, announced the investigation of the Signal Complexity™...

CSL Enters Licensing Agreement with Arcturus Therapeutics for Next Generation mRNA Vaccine Technology

CSL Limited announces that its subsidiary, CSL Seqirus, has entered into a collaboration and license agreement with Arcturus Therapeutics Holdings Inc ("Arcturus Therapeutics") to...

Ascletis Announces U.S. IND Filing of Oral 3CLpro Inhibitor ASC11 for COVID-19

Ascletis Pharma Inc. announces that the Investigational New Drug (IND) application of ASC11, an oral inhibitor drug candidate targeting 3-chymotrypsin like protease (3CLpro) for...
0FansLike
0FollowersFollow
spot_img

Hot Topics